Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -Q1 group results

Aug 9 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Jun 30, 2019        Jun 30, 2018      Mar 31, 2020 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            256 mln             254 mln            1.43     
                 (+0.8 pct)          (+20.6 pct)      (+31.8 pct)  
  Operating     loss 225 mln        loss 221 mln      loss 756 mln 
  Recurring     loss 229 mln         loss 97 mln      loss 687 mln 
  Net           loss 229 mln         loss 80 mln      loss 687 mln 
  EPS           loss 3.23 yen       loss 1.25 yen    loss 9.66 yen 
  Ann Div                                NIL              NIL      
  -Q2 div                                NIL              NIL      
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news